Cdk2/Cyclin Inhibitory Peptide II
Modify Date: 2024-01-10 10:41:59
Cdk2/Cyclin Inhibitory Peptide II structure
|
Common Name | Cdk2/Cyclin Inhibitory Peptide II | ||
|---|---|---|---|---|
| CAS Number | 237392-85-7 | Molecular Weight | 2595.07 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C110H200N48O25 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cdk2/Cyclin Inhibitory Peptide IICdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1]. |
| Name | Cdk2/Cyclin Inhibitory Peptide II |
|---|
| Description | Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK[1]. |
| In Vitro | Cdk2/Cyclin Inhibitory Peptide II (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: U2OS osteosarcoma cells Concentration: 0-150 µM Incubation Time: 24 h Result: Exhibited good activity to kill U2OS osteosarcoma cells. |
| Molecular Formula | C110H200N48O25 |
|---|---|
| Molecular Weight | 2595.07 |